Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Type II sectection within A. baumannii (WT vs gspD)

ABSTRACT: Comparsion of the secretome of A. baumannii (WT vs gspD)

INSTRUMENT(S):

ORGANISM(S): Acinetobacter Calcoaceticus/baumannii Complex

SUBMITTER: Nichollas Scott

LAB HEAD: Mario F. Feldman

PROVIDER: PXD030491 | Pride | 2022-04-06

REPOSITORIES: Pride

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	MQ_searches.zip	Other
	NSco_NS_403_20200226_AB_secretome_G_UPAB1_B1.raw	Raw
	NSco_NS_403_20200226_AB_secretome_G_UPAB1_B2.raw	Raw
	NSco_NS_403_20200226_AB_secretome_G_UPAB1_B3.raw	Raw
	NSco_NS_403_20200226_AB_secretome_G_UPAB1_B4.raw	Raw

Items per page:

1 - 5 of 12

Similar Datasets

Sectection analysis of A. baumannii (WT vs gspD vs HlyD1 vs HlyD2 vs RTX)

Project description:Comparsion of the secretome of A. baumannii (WT vs gspD vs HlyD1 vs HlyD2 vs RTX)

2022-04-06 | PXD030460 | Pride

Quantitative analysis of the acinetoabcter baumannii proteome in response to Diclofenac and Colistin

Project description:Quantitative analysis of the acinetoabcter baumannii proteome in response to Diclofenac and Colistin

2024-10-24 | PXD047586 | Pride

UPAB1 secretome analysis of hlyD1 vs hlyD2 vs Wt.

Project description:A. baumannii UPAB1 secretome analysis of hlyD1 vs Wt and hlyD2 vs Wt.

2021-08-09 | PXD024736 | Pride

RNA sequencing of ATCC 17978hm Acineotbacter baumannii strain and CpdA mutant

Project description:Difference in RNA expression levels between Acinetobacter baumannii cells expressing high and low levels of cyclic AMP Total RNA obtained from Acineotbacter baumannii bacterial cells in Log phase gown in MH broth culture, isolated RNA in triplicate from three expreiment. cpdA::Tn mutant and 17978hm strain compared. Assessing increased levels of cAMP within the cell

2015-06-21 | E-GEOD-64935 | biostudies-arrayexpress

Blockage of O-linked glycan biosynthesis in Burkholderia is toxic: DIA analysis of OGC mutants

Project description:Burkholderia species are associated with several life-threatening human infections, often resulting in high morbidity and mortality rates due to their innate resistance to antibiotics. To improve clinical outcomes, new therapies targeting conserved, yet unique, Burkholderia pathways are needed. One such pathway is the Burkholderia O-linked protein glycosylation system, essential for virulence in Burkholderia cenocepacia and Burkholderia pseudomallei. This system relies on the O-Glycosylation gene Cluster (OGC), a five-gene cluster sufficient and required for the generation of a trisaccharide β-Gal-(1,3)–α-GalNAc-(1,3)–β-GalNAc used for protein glycosylation, and the distally encoded oligosaccharyltransferase, pglL, responsible for ligating glycans to glycoproteins. Previous work has shown that the OGC cluster can be removed, but individual mutations associated with late-stage glycan biosynthesis are essential. Here, we explore the essentiality of late-stage O-linked glycan biosynthesis in B. cenocepacia, revealing that the completion and translocation of the O-linked trisaccharide is necessary for viability and bacterial fitness. Using inducible systems, we demonstrate toxicity dependent on multiple OGC genes and the initiation of O-linked glycan biosynthesis. Upon loss of late-stage biosynthesis, mutants exhibit notable growth defects and profound sensitivity to stresses. Proteomics and glycoproteomic analysis show that blocking late-stage glycan biosynthesis inhibits protein glycosylation and drives large membrane proteomic changes. Finally, we demonstrate that OGC mediated toxicity is not limited to blockages but can also occur via the overexpression of steps within O-linked glycan biosynthesis. Combined, these findings suggest that the O-linked glycan biosynthesis pathway of B. cenocepacia is extremely sensitive to dysregulation and may be an ideal target for the development of antimicrobial therapies.

2025-10-22 | PXD054949 | Pride

CBU1543 immunopercipation (CBU1543 vs empty vector)

Project description:immunopercipation of CBU1543 to identify interaction partners

2023-08-07 | PXD030191 | Pride

PAA and the A. baumannii ATCC17978 proteome

Project description:Analysis of proteome changes in respond to PAA, PAA+ST, DMSO and ST.

2022-04-06 | PXD025651 | Pride

Blockage of O-linked glycan biosynthesis in Burkholderia is toxic: OgcI Complementation

2025-10-22 | PXD054867 | Pride

neisserial OTases have different protein specificies

Project description:Proteomic investigation on the glycosylation substrates and proteome effects of altering neisserial OTases within the proteome of N. gonorrhoeae MS11

2022-04-04 | PXD024737 | Pride

Blockage of O-linked glycan biosynthesis in Burkholderia is toxic: Overexpression of OgcX in OGC mutant backgrounds

Project description:Burkholderia species are associated with several life-threatening human infections, often resulting in high morbidity and mortality rates due to their innate resistance to antibiotics. To improve clinical outcomes, new therapies targeting conserved, yet unique, Burkholderia pathways are needed. One such pathway is the Burkholderia O-linked protein glycosylation system, essential for virulence in Burkholderia cenocepacia and Burkholderia pseudomallei. This system relies on the O-Glycosylation gene Cluster (OGC), a five-gene cluster sufficient and required for the generation of a trisaccharide Gal-GalNAc-GalNAc used for protein glycosylation, and the distally encoded oligosaccharyltransferase, pglL, responsible for ligating glycans to glycoproteins. Previous work has shown that the OGC cluster can be removed, but individual mutations associated with late-stage glycan biosynthesis are essential. Here, we explore the essentiality of late-stage O-linked glycan biosynthesis in B. cenocepacia, revealing that the completion and translocation of the O-linked trisaccharide is necessary for viability and bacterial fitness. Using inducible systems, we demonstrate toxicity dependent on multiple OGC genes and the initiation of O-linked glycan biosynthesis. Upon loss of late-stage biosynthesis, mutants exhibit notable growth defects and profound sensitivity to stresses. Proteomics and glycoproteomic analysis show that blocking late-stage glycan biosynthesis inhibits protein glycosylation and drives large membrane proteomic changes. Finally, we demonstrate that OGC mediated toxicity is not limited to blockages but can also occur via the overexpression of steps within O-linked glycan biosynthesis. Combined, these findings suggest that the O-linked glycan biosynthesis pathway of B. cenocepacia is extremely sensitive to dysregulation and may be an ideal target for the development of antimicrobial therapies.

2025-10-22 | PXD059283 | Pride